This is in support of the defined study purpose, which was not to understand the host-specific VEGF response but to investigate a novel, αvß3-integrin-targeted radiotracer for monitoring anti-angiogenic effects in a small animal model of human breast cancer. The gene discussed is VEGFA; the disease is breast cancer.